HIV and AIDS Trial, Recruiting (NCT06880224)

HIV and AIDS Trial, Recruiting NCT06880224 Sponsor: Northwestern University Condition: HIV and AIDS

Printed from Voxsanity (voxsanity.com.au) — NCT06880224 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Hiv Aids

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the HIV Case Finding part of the trial (which includes a PrEP component):

People aged 15 to 24
People who were assigned male at birth, regardless of their current gender identity
People who can understand basic English, Yoruba, Hausa, Igbo, or Pidgin English
For the PrEP component specifically, people who have tested negative for HIV

For the HIV Treatment part of the trial:

People aged 15 to 24
People who have tested positive for HIV
People who are starting HIV treatment (ART) for the first time at a participating clinic or satellite clinic
People who can understand basic English, Yoruba, Hausa, Igbo, or Pidgin English
People who plan to continue attending the participating clinic throughout the follow-up period

Who may not be able to join:

People who are not able to give their own consent to participate
People who are 15 years old, are not legally independent, and do not have a parent or guardian's permission to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert Garofalo, MD, Northwestern University

Phone: 312-227-7740

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06880224

Sponsor: Northwestern University

Phase: Not Applicable

Status: Recruiting

Condition: HIV and AIDS

Trial contact: 312-227-7740

More information: https://clinicaltrials.gov/study/NCT06880224

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

For the HIV Case Finding part of the trial (which includes a PrEP component):

People aged 15 to 24
People who were assigned male at birth, regardless of their current gender identity
People who can understand basic English, Yoruba, Hausa, Igbo, or Pidgin English
For the PrEP component specifically, people who have tested negative for HIV

For the HIV Treatment part of the trial:

People aged 15 to 24
People who have tested positive for HIV
People who are starting HIV treatment (ART) for the first time at a participating clinic or satellite clinic
People who can understand basic English, Yoruba, Hausa, Igbo, or Pidgin English
People who plan to continue attending the participating clinic throughout the follow-up period

Who may not be able to join:

People who are not able to give their own consent to participate
People who are 15 years old, are not legally independent, and do not have a parent or guardian's permission to participate

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Northwestern University

Registry

ClinicalTrials.gov

Start date

1 February 2025

Est. completion

31 August 2028

Where this trial is recruiting

Nigeria

Primary endpoints

Case Finding: HIV-positive serostatus; Treatment: Viral suppression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov